Healthcare provider profile · identity verified

Daniel Hanba, MD

Internal Medicine · KALISPELL, MT · NPI 1497142681

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	725	198
Levothyroxine Sodium	Levothyroxine Sodium	481	112
Amlodipine Besylate	Amlodipine Besylate	386	111
Lisinopril	Lisinopril	358	95
Omeprazole	Omeprazole	354	93
Losartan Potassium	Losartan Potassium	328	87
Rosuvastatin Calcium	Rosuvastatin Calcium	244	64
Metoprolol Succinate	Metoprolol Succinate	238	72
Tamsulosin Hcl	Tamsulosin Hcl	237	60
Hydrochlorothiazide	Hydrochlorothiazide	159	44
Metformin Hcl	Metformin Hcl	151	38
Gabapentin	Gabapentin	148	41
Simvastatin	Simvastatin	138	37
Allopurinol	Allopurinol	137	37
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	127	24
Potassium Chloride	Potassium Chloride	127	36
Metoprolol Tartrate	Metoprolol Tartrate	124	35
Meloxicam	Meloxicam	123	34
Furosemide	Furosemide	119	35
Sertraline Hcl	Sertraline Hcl	119	33
Eliquis	Apixaban	107	27
Metformin Hcl Er	Metformin Hcl	106	28
Albuterol Sulfate Hfa	Albuterol Sulfate	105	47
Clopidogrel	Clopidogrel Bisulfate	97	29
Trazodone Hcl	Trazodone Hcl	94	25
Lorazepam	Lorazepam	90	22
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	83	20
Carvedilol	Carvedilol	82	20
Tramadol Hcl	Tramadol Hcl	79	23
Warfarin Sodium	Warfarin Sodium	79	19
Pantoprazole Sodium	Pantoprazole Sodium	71	22
Montelukast Sodium	Montelukast Sodium	68	17
Escitalopram Oxalate	Escitalopram Oxalate	64	20
Finasteride	Finasteride	63	14
Ezetimibe	Ezetimibe	59	22
Fluoxetine Hcl	Fluoxetine Hcl	56	12
Trulicity	Dulaglutide	55	suppressed
Celecoxib	Celecoxib	54	12
Duloxetine Hcl	Duloxetine Hcl	54	15
Alendronate Sodium	Alendronate Sodium	53	18
Glipizide Er	Glipizide	49	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	49	13
Pregabalin	Pregabalin	46	suppressed
Donepezil Hcl	Donepezil Hcl	44	17
Zolpidem Tartrate	Zolpidem Tartrate	44	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	43	16
Benazepril Hcl	Benazepril Hcl	42	suppressed
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Prednisone	Prednisone	40	16
Citalopram Hbr	Citalopram Hydrobromide	37	11
Telmisartan	Telmisartan	37	suppressed
Irbesartan	Irbesartan	36	suppressed
Nifedipine Er	Nifedipine	36	suppressed
Atenolol	Atenolol	34	suppressed
Chlorthalidone	Chlorthalidone	34	suppressed
Fluticasone Propionate	Fluticasone Propionate	34	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	33	suppressed
Glipizide	Glipizide	32	suppressed
Terazosin Hcl	Terazosin Hcl	32	suppressed
Breo Ellipta	Fluticasone/Vilanterol	31	suppressed
Jardiance	Empagliflozin	31	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	31	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Mirtazapine	Mirtazapine	27	13
Advair Hfa	Fluticasone Propion/Salmeterol	26	suppressed
Famotidine	Famotidine	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Synthroid	Levothyroxine Sodium	26	suppressed
Rybelsus	Semaglutide	25	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	25	suppressed
Ventolin Hfa	Albuterol Sulfate	25	suppressed
Lovastatin	Lovastatin	24	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Bupropion Xl	Bupropion Hcl	22	suppressed
Diazepam	Diazepam	22	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	22	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	22	11
Spironolactone	Spironolactone	22	suppressed
Bupropion Hcl Sr	Bupropion Hcl	21	suppressed
Tizanidine Hcl	Tizanidine Hcl	21	suppressed
Alprazolam	Alprazolam	20	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	20	suppressed
Ondansetron Odt	Ondansetron	20	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	20	suppressed
Topiramate	Topiramate	20	suppressed
Enalapril Maleate	Enalapril Maleate	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	18	suppressed
Valacyclovir	Valacyclovir Hcl	18	suppressed
Azithromycin	Azithromycin	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	17	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Methimazole	Methimazole	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	12
Baclofen	Baclofen	16	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	16	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Droplet Pen Needle	Pen Needle, Diabetic	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Mounjaro	Tirzepatide	14	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	14	suppressed
Potassium Citrate Er	Potassium Citrate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Calcitriol	Calcitriol	13	suppressed
Estradiol (Once Weekly)	Estradiol	13	suppressed
Fenofibrate	Fenofibrate	13	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	13	suppressed
Prazosin Hcl	Prazosin Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Gemfibrozil	Gemfibrozil	12	suppressed
Lansoprazole	Lansoprazole	12	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Naproxen	Naproxen	12	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	11	suppressed
Torsemide	Torsemide	11	suppressed
Valsartan	Valsartan	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error